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Abstract 1 
Although psychodynamic therapy (PDT) is an evidence-based intervention for a broad spectrum 2 
of psychiatric conditions, there is often notable bias in the way PDT is depicted both in the 3 
popular media and in the scientific literature. This has contributed to a negative view of PDT, 4 
which hampers both patient access to this treatment and researcher access to funding for further 5 
research on PDT. The adverse effects of these distortions and biases are detrimental not only to 6 
PDT but also to the overall field of psychotherapy, raising questions about its credibility. Here we 7 
summarize current evidence for PDT, describe existing biases, and formulate a set of 8 
recommendations to foster a more balanced perspective on PDT.  9 
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Introduction to Guest Column 1 
Eric M. Plakun, MD 2 
Psychotherapy Section Editor 3 
 4 
This column had its origins on the 161st birthday of Sigmund Freud on May 6, 2017, 5 
while I was listening to Garrison Keillor’s Writer’s Almanac piece for that day on National 6 
Public Radio. Keillor cited Freud’s birthday in his piece, but after describing Freud’s seminal 7 
work on dreams and his focus on the centrality of unconscious factors in determining 8 
human behavior, Keillor concluded his comments by stating that science had by now largely 9 
debunked Freud’s theories. I was dumbstruck by this offhanded and completely inaccurate 10 
statement from a usually knowledgeable radio commentator. It reminded me of other 11 
examples I had come across of gross misinformation and bias with respect to 12 
psychoanalysis and psychodynamic therapy. For example, among general psychiatrist 13 
colleagues with whom I work in the American Psychiatric Association (APA) Assembly, no 14 
one would ever utter a joke about a minority group, but periodic jokes poking fun at 15 
psychoanalysts still turn up now and then. About a month later, I saw the PsychiatryOnline 16 
version of a paper by Christiane Steinert1 and her group that was in press in the American 17 
Journal of Psychiatry, reporting “equivalence” of psychodynamic therapy with other forms 18 
of therapy. I knew then that I wanted to do a column on the problem of implicit bias toward 19 
psychodynamic therapy and psychoanalysis.  20 
As I hope has been clear in all of these columns to date, they are about 21 
psychotherapy in general and do not favor one school of psychotherapy over another. We 22 
have too much work to do together to persuade a field that tends toward biological 23 
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reductionism in its thinking about etiology and treatment of disorders for this column or 1 
this columnist to join the proverbial “circular firing squad,” in which psychotherapists from 2 
competing schools argue with one another about who has the best therapy or the best 3 
research. This implicit bias, as the guest columnists show, goes beyond needless 4 
competition between schools and it reflects poorly on the credibility of psychotherapy as a 5 
form of treatment and on the quality of psychotherapy research of all kinds. It also runs 6 
counter to the recommendation from the Institute of Medicine's Report on Psychosocial 7 
Interventions in Mental Health and Substance Use Disorders that we increase efforts to 8 
identify shared elements across forms of therapy that are associated with change.2 We 9 
cannot allow implicit bias to lead us to ignore science. I am delighted and grateful that these 4 10 
leading psychodynamic therapy researchers agreed to take on the task of describing these biases, 11 
citing evidence that unmasks them, and making recommendations to move forward. 12 
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Bias Toward Psychodynamic Therapy: Framing the Problem and Working Toward a 1 
Solution 2 
Guest Columnists: Allan Abbass, Patrick Luyten, Christiane Steinert and Falk Leichsenring 3 
 Psychodynamic therapy (PDT) as a family of treatments is an evidence-based intervention 4 
for a broad spectrum of psychiatric conditions.
3–5
 PDT has been shown to be as effective as other 5 
psychosocial interventions, including the family of treatments known under the rubric of 6 
cognitive behavioral therapy (CBT).
6
 Despite this, PDT continues to receive what appears to be 7 
biased treatment in treatment guidelines, reviews, and related publications, and in media that 8 
inform the public’s perception and ultimately patient access to this effective treatment modality. 9 
 10 
EVIDENCE FOR PDT 11 
 The efficacy and effectiveness of PDT for common mental disorders have been supported 12 
by several systematic reviews and meta-analyses. A Cochrane review investigating the efficacy 13 
of brief (under 40 sessions) PDT for common mental disorders, for instance, found that PDT 14 
outperformed wait-list, treatment as usual, and minimal contact comparisons at both short- and 15 
long- term follow-up.
3
 Longer-term psychodynamic therapy has been found to be effective in 16 
complex mental disorders, including in patients with personality disorders, chronic mental 17 
disorders, or multiple mental disorders.
7–9
 In complex mental disorders, the longer term versions 18 
of PDT appear more effective than short-term therapies. According to the Chambless and Hollon 19 
criteria
10
 for empirically supported therapies, PDT is "efficacious" or "probably efficacious" in 20 
most common mental disorders.
11
 In addition, meta-analyses have found no statistically 21 
significant differences in outcome between individual PDT and other forms of individual 22 
psychotherapy in patients with anxiety or depressive disorders,
12,13
 and in patients with more 23 
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complex mental disorders.
14,15
 A recent meta-analysis specifically designed to test for 1 
equivalence in outcomes found PDT to be as efficacious as treatments with established efficacy, 2 
such as CBT, across various mental disorders.
6
  3 
 4 
BIAS IN THE DEPICTION OF PDT 5 
 Despite the evidence for PDT, biases in the depiction of PDT and of PDT research remain, 6 
and threaten to reduce the further development of and thereby limit patient access to PDT. Many 7 
of these biases appear to be due to 5 general biases that have been documented in scientific 8 
research, most notably researcher allegiance and the application of double standards.
16,17
 9 
 10 
Bias 1. Distorted Depictions of Psychodynamic Therapy as a Science 11 
 Many textbooks of clinical psychology and basic psychology describe psychodynamic 12 
approaches, at best, as historically important in psychology’s development, but as currently out-13 
dated and obsolete. At worst, psychodynamic approaches are depicted as unscientific or even 14 
pseudoscientific.
18
 What these depictions have in common is that they are typically based on 15 
caricatured versions of early psychoanalytic assumptions (example: repressed libido as the only 16 
dynamic force) while ignoring contemporary psychodynamic approaches and the considerable 17 
empirical evidence for these views that has emerged over the past few decades.
19
 Unfortunately, 18 
this distorted image of current PDT has penetrated popular media and university curricula, 19 
damaging the perspectives of both mental health professionals and prospective patients.
20,21
 20 
 21 
Bias 2. Exclusion or Distortion of Evidence Related to PDT in Treatment Guidelines  22 
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 Several treatment guidelines exclude or downgrade PDT, often under the guise of the 1 
purportedly smaller evidence base for PDT, even though a higher number studies does not in and 2 
of itself provide evidence for superiority. For instance, in the treatment of anxiety disorders, a 3 
recent meta-analysis
22
 showed that more than 80% of 121 trials of CBT focusing on anxiety 4 
disorders used wait-list control groups; only 17% of studies were of high quality. But even when 5 
there are a large number of trials available for PDT of a specific condition, this does not 6 
necessarily lead to comparable and unbiased presentation of PDT. For instance, the recently 7 
published Canadian Guidelines for the Management of Adults with Major Depressive Disorder 8 
(Canadian Network for Mood & Anxiety Disorders or CANMAT)
23
 placed brief PDT as a 9 
second- rather than a first-line treatment for depression, despite citing a 54 study meta-analysis 10 
showing large persistent effects and equal effects between individual PDT and other individual 11 
treatment modalities.
12
 Furthermore, even when this inconsistency was pointed out, the guideline 12 
committee did not revise its conclusions and also neglected to consider the outcomes of large 13 
studies showing non-inferiority of PDT to CBT.
24
 A similar struggle occurred recently in Sweden 14 
where the National Board of Health and Welfare recruited a skewed mix of professionals to 15 
develop treatment guidance: the opinions of the few PDT professionals were outvoted leading to 16 
guidance undervaluing PDT.
25
 17 
 Research bodies such as the U.S. National Institute of Mental Health similarly appear to 18 
perpetuate distorted or biased information about PDT.
26
 For example, under the categories of 19 
anxiety disorders, borderline personality disorder, depression, and eating disorders, there is no 20 
mention of PDT as a valid treatment option. In a separate section describing psychotherapies,
27
 21 
there is a notable absence of discussion of psychodynamic as well as other contributions to 22 
psychotherapy. The focus in these descriptions is on cognitive and behavioral processes, while 23 
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the language used is typical of CBT, which could mislead the public to believe that the only 1 
relevant psychotherapy approach is CBT. 2 
As another example, a recent comprehensive review of psychosocial interventions in 3 
anxiety disorders
28
 completely downplayed the evidence for PDT in the treatment of these 4 
disorders, even when confronted with evidence from meta-analyses showing similar effects of 5 
PDT compared with other treatments in these conditions.
13.29
. 6 
 7 
Bias 3. Exclusion of Psychodynamic Researchers From Funding and Guidelines 8 
Committees  9 
 Although there are considerable regional differences, psychodynamic researchers are 10 
often excluded from committees responsible for developing treatment guidelines or for reviewing 11 
research and making decisions about research funding. For example, the CANMAT group 12 
mentioned above initially included PDT researchers, but they were subsequently removed from 13 
the group without explanation, leaving PDT data to be interpreted by researchers with allegiances 14 
to different schools of therapy.
30
  15 
 16 
Bias 4. Use of Neutered Versions of “Psychodynamic Therapy” in Randomized Clinical 17 
Trials: The “Straw Man” Bias 18 
 A particularly pernicious problem has been the use of neutered versions of 19 
―psychodynamic therapy‖ in some trials. For example, in a study of posttraumatic stress disorder, 20 
therapists delivering the PDT model were restricted from speaking about the trauma itself, a 21 
withholding that patients must have found both unusual and frustrating.
31
 The use of diluted PDT 22 
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methods as ―straw man‖ controls that are intended to fail was described for the first time more 1 
than three decades ago by Smith et al
32: ―A comparison condition might be set up as a kind of 2 
straw man over which the favored therapy would prevail. The comparison condition (often an 3 
´insight therapy´) would be treated with fairly obvious disdain, and would not be given as much 4 
opportunity for success‖ (p. 119). Surprisingly, this bias still exists, as has been amply 5 
documented in a number of recent reviews.
16,33.34
 This bias among others affects the replicability, 6 
validity, and credibility of all psychotherapy research.
35
 7 
 8 
Bias 5. Biased Study Selection in Meta-Analyses 9 
 The selection of studies in meta-analyses is frequently biased against PDT. It has been 10 
easy to demonstrate that, in some meta-analyses, typically including researchers with allegiance 11 
to a single and different form of therapy, study selection is performed in ways that exclude valid 12 
PDT studies, on the one hand, and that include flawed PDT studies, on the other. A meta-analysis 13 
by Marcus et al.,36 for example, which purportedly claimed to investigate the effectiveness of 14 
CBT versus other treatment modalities (including PDT) included only three questionable studies 15 
of PDT, but omitted a large number of RCTs comparing PDT with other bona fide 16 
psychotherapies. Baardseth et al.
37
 showed that several studies of bona fide psychotherapies, 17 
including PDT, were excluded in a similar way for unclear reasons in another meta-analysis 18 
purporting to find a consistent advantage for a particular family of treatments.
38
 Table 1 lists the 19 
varieties of bias toward PDT. 20 
 21 
A WAY FORWARD 22 
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 If this problem of bias is not addressed, we not only risk that patients will be denied 1 
access to effective treatments, but we miss the opportunity for dialogue and collaboration that 2 
could enhance the credibility of scientific psychosocial interventions— at present, the credibility 3 
of research in psychology is severely questioned.
39
 We propose the following steps to help move 4 
the field in a more sensible and healthy direction. These recommendations are in accordance with 5 
Chambers´ manifesto 
39
 for reforming the culture of scientific practice.  6 
 Clearly, for the public to have balanced information, researchers and clinicians who are 7 
knowledgeable about the current literature on PDT should be routinely included in committees 8 
charged with guideline development, funding decisions, webpage publications, and organizations 9 
furthering psychotherapy as a collective treatment approach. Furthermore, researcher allegiances 10 
and other conflicts of interest should be collected and consistently disclosed, so readers have a 11 
context for the materials.  12 
 Given the shared objective of all psychotherapy proponents to increase the effectiveness 13 
and scope of psychosocial interventions, collaborative research should be done using what has 14 
been called ―adversarial collaboration‖ to further develop psychotherapy as a collective. Those 15 
conducting meta-analyses and review groups should consult with researchers from other models 16 
beyond the allegiance of the core group to yield a richer synthesis and contextualization of 17 
findings. Finally, shared research should continue on key therapy elements versus overall therapy 18 
models toward identifying which interventions work best for whom. This may be especially 19 
relevant in relation to therapeutic factors such as emotional experience/exposure
40
 or change in 20 
person-environment exchanges 
41
 as presumed key ingredients across treatment modalities. Table 21 
2 lists recommendations for corrective action. 22 
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